How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code QOF: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents. View classification details, related manufacturers, 510(k) clearances, and recall records.
A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.Explore microbiology records →
38 clearance records and 9 recall records in the covered releases, across 19 source company names and 1 product codes. Dated history runs from Feb 1, 2023 to Oct 30, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 1 | 1 |
| November 2025 | 0 | 0 |
| December 2025 | 1 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 1 | 0 |
| March 2026 | 1 | 0 |
| April 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| June 2026 | 1 | 1 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 3 | 0 |
| October 2026 | 3 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| QOF · Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents | 38 | 9 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Xpert Xpress CoV-2/Flu/RSV plusK242071 · QOF | Cepheid | 510(k) | Jan 10, 2025FDA decision date |
| Applied Biosystems TaqPath COVID-19, Flu A, Flu B, RSV Select PanelK241806 · QOF | Life Technologies Corporation | 510(k) | Jan 8, 2025FDA decision date |
| DASH® SARS-CoV-2 & Flu A/B TestK241652 · QOF | Nuclein, LLC | 510(k) | Dec 20, 2024FDA decision date |
| Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, REF: PRD-07400Z-0694-2025 · QOF | Hologic, Inc. | Recall | Dec 20, 2024FDA classification date |
| Panther Fusion SARS-CoV-2/Flu A/B/RSV assayK242465 · QOF | Hologic, Inc. | 510(k) | Nov 15, 2024FDA decision date |
| QIAstat-Dx Respiratory Panel MiniK242353 · QOF | QIAGEN GmbH | 510(k) | Oct 25, 2024FDA decision date |
| Panther Fusion SARS-CoV-2/Flu A/B/RSV AssayK241240 · QOF | Hologic, Inc. | 510(k) | Jul 18, 2024FDA decision date |
| BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel MiniK241194 · QOF | Biofire Diagnostics, LLC | 510(k) | May 30, 2024FDA decision date |
| QIAstat-Dx® Respiratory Panel PlusK233100 · QOF | QIAGEN GmbH | 510(k) | May 10, 2024FDA decision date |
| BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) PanelK232954 · QOF | Biofire Diagnostics, LLC | 510(k) | Mar 26, 2024FDA decision date |
| NxTAG Respiratory Pathogen Panel v2 (NxTAG RPP v2)K231758 · QOF | Luminex Molecular Diagnostics, Inc. | 510(k) | Mar 11, 2024FDA decision date |
| LIAISON PLEX Respiratory Flex AssayK233410 · QOF | Luminex Corporation | 510(k) | Mar 1, 2024FDA decision date |
| The BIOFIRE Respiratory Panel 2.1 (RP2.1) is a PCR-based multiplexed nucleic acid test intended for use with the BIOFIRE FILMARRAY 2.0 or BIOFIRE…Z-0704-2024 · QOF | BioFire Diagnostics, LLC | Recall | Jan 10, 2024FDA classification date |
| BioFire Respiratory Panel 2.1 (RP2.1), REF: 423742, For FILMARRAY systems, IVD, Rx OnlyZ-2439-2023 · QOF | BioFire Diagnostics, LLC | Recall | Aug 21, 2023FDA classification date |
| Xpert Xpress CoV-2/Flu/RSV plusK231481 · QOF | Cepheid® | 510(k) | Aug 17, 2023FDA decision date |
| BD Respiratory Viral Panel for BD MAX System; BD Respiratory Viral Panel-SCV2 for BD MAX SystemK230956 · QOF | Bd Integrated Diagnostic Solutions / | 510(k) | Jul 31, 2023FDA decision date |
| cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® SystemK223591 · QOF | Roche Molecular Systems, Inc. | 510(k) | Jul 27, 2023FDA decision date |
| Panther Fusion SARS-CoV-2/Flu A/B/RSV AssayK222736 · QOF | Hologic, Inc. | 510(k) | May 16, 2023FDA decision date |
| BIOFIRE® SPOTFIRE® Respiratory (R) Panel MiniK230719 · QOF | Biofire Diagnostics, LLC | 510(k) | Apr 13, 2023FDA decision date |
| Simplexa COVID-19 & Flu A/B DirectK220963 · QOF | Diasorin Molecular, LLC | 510(k) | Mar 17, 2023FDA decision date |
| In Vitro Diagnostic (IVD) Panel BioFire Respiratory Panel 2.1 (RP2.1) - REF 423742Z-1252-2023 · QOF | BioFire Diagnostics, LLC | Recall | Mar 15, 2023FDA classification date |
| BIOFIRE SPOTFIRE Respiratory (R) PanelK213954 · QOF | Biofire Diagnostics | 510(k) | Feb 3, 2023FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.